📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Aegerion Pharmaceuticals

1.1 - Company Overview

Aegerion Pharmaceuticals Logo

Aegerion Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapeutics to treat cardiovascular and metabolic diseases, focused on the development and commercialization of therapies, including lomitapide (AEGR-733), a microsomal triglyceride transfer protein inhibitor small molecule drug designed to decrease serum lipids.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Aegerion Pharmaceuticals

Bellerophon Therapeutics Logo

Bellerophon Therapeutics

HQ: United States Website
  • Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
Orchestra BioMed Logo

Orchestra BioMed

HQ: United States Website
  • Description: Provider of biomedical solutions for procedure-based medicine: BackBeat CNT (investigational bioelectronic treatment for hypertension to reduce blood pressure and modulate autonomic nervous system responses); Virtue SAB (investigational drug/device delivering sirolimus during angioplasty without coating or permanent implants); and FreeHold Retractors for hands-free surgical retraction to improve visualization and procedural efficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orchestra BioMed company profile →
VerAvanti Logo

VerAvanti

HQ: United States Website
  • Description: Provider of single-use intravascular endoscopic technologies, including a Scanning Fiber Endoscope delivering real-time, high-resolution images of intravascular anatomy to help diagnose and treat stroke and cardiovascular events; in-house MEMS manufacturing of micro-small components using precise robotics and cleanroom assembly; and O-pH imaging to measure oral biofilm acidity to predict and manage tooth decay.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VerAvanti company profile →
Lifebridge Logo

Lifebridge

HQ: Germany Website
  • Description: Provider of novel therapy for use by cardiologists, cardiovascular surgeons, and ER physicians to treat patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lifebridge company profile →
Navilyst Medical Logo

Navilyst Medical

HQ: United States Website
  • Description: Provider of medical devices focused on fluid management and vascular access, formed from Boston Scientific’s Fluid Management and Vascular Access units. Offers devices including PASV Valve Technology, an expanded line of Xcela Power Injectable PICCs, and NAMIC fluid management products; develops, manufactures, and markets these solutions. Headquartered in Marlborough, MA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Navilyst Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Aegerion Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Aegerion Pharmaceuticals

2.2 - Growth funds investing in similar companies to Aegerion Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Aegerion Pharmaceuticals

4.2 - Public trading comparable groups for Aegerion Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Aegerion Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Aegerion Pharmaceuticals

What does Aegerion Pharmaceuticals do?

Aegerion Pharmaceuticals is a provider of biopharmaceutical therapeutics to treat cardiovascular and metabolic diseases, focused on the development and commercialization of therapies, including lomitapide (AEGR-733), a microsomal triglyceride transfer protein inhibitor small molecule drug designed to decrease serum lipids.

Who are Aegerion Pharmaceuticals's competitors?

Aegerion Pharmaceuticals's competitors and similar companies include Bellerophon Therapeutics, Orchestra BioMed, VerAvanti, Lifebridge, and Navilyst Medical.

Where is Aegerion Pharmaceuticals headquartered?

Aegerion Pharmaceuticals is headquartered in United States.

How many employees does Aegerion Pharmaceuticals have?

Aegerion Pharmaceuticals has 1,000 employees 🔒.

When was Aegerion Pharmaceuticals founded?

Aegerion Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Aegerion Pharmaceuticals in?

Aegerion Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Aegerion Pharmaceuticals

Who are the top strategic acquirers in Aegerion Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Aegerion Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Aegerion Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Aegerion Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Aegerion Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Aegerion Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Aegerion Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Aegerion Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Aegerion Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Aegerion Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Aegerion Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Aegerion Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Aegerion Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Aegerion Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Aegerion Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Aegerion Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Aegerion Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Aegerion Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Aegerion Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Aegerion Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Aegerion Pharmaceuticals